Evidence map›Paper›PMID 26213431›Full record

ArticleTrends in analytical chemistry : TRAC2015

Using fragmentation trees and mass spectral trees for identifying unknown compounds in metabolomics.

Arpana Vaniya, Oliver Fiehn

Abstract read
In one paragraph

Article in Trends in analytical chemistry : TRAC, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. Article
  2. Article
  3. Phytochemical Composition of Clonally PropagatedMolecules (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Frontiers in pharmacology · 2026
    Article
  6. Article
  7. Article
  8. MSNature methods · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Arpana VaniyaUniversity of California Davis, Department of Chemistry, One Shields Avenue, Davis, CA 95616, USA ; University of California Davis, West Coast Metabolomics Center, Genome Center, 451 Health Sciences Drive, Davis, CA 95616, USA.
Oliver FiehnUniversity of California Davis, West Coast Metabolomics Center, Genome Center, 451 Health Sciences Drive, Davis, CA 95616, USA ; King Abdulaziz University, Biochemistry Department, Jeddah, Saudi Arabia.

Funding

West Coast Central Comprehensive Metabolomics Resource Core (WC3MRC)U24DK097154 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIEHN, OLIVER · 2012 to 2017
$9.9M
NIDDK NIH HHS U24 DK097154
6 · The paper itself

Abstract

Identification of unknown metabolites is the bottleneck in advancing metabolomics, leaving interpretation of metabolomics results ambiguous. The chemical diversity of metabolism is vast, making structure identification arduous and time consuming. Currently, comprehensive analysis of mass spectra in metabolomics is limited to library matching, but tandem mass spectral libraries are small compared to the large number of compounds found in the biosphere, including xenobiotics. Resolving this bottleneck requires richer data acquisition and better computational tools. Multi-stage mass spectrometry (MSn) trees show promise to aid in this regard. Fragmentation trees explore the fragmentation process, generate fragmentation rules and aid in sub-structure identification, while mass spectral trees delineate the dependencies in multi-stage MS of collision-induced dissociations. This review covers advancements over the past 10 years as a tool for metabolite identification, including algorithms, software and databases used to build and to implement fragmentation trees and mass spectral annotations.

Indexed as

Fragmentation treeIon treeMass spectral treeMass spectrometryMetabolite identificationMetabolomicsMSnMulti-stage analysisTandem mass spectrometryUnknown compound

Identifiers

PMID26213431
PMCPMC4509603

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.